• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Hebert Curtis L Jr

    12/13/24 5:11:28 PM ET
    $IVCP
    Blank Checks
    Finance
    Get the next $IVCP alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    HEBERT CURTIS L JR

    (Last) (First) (Middle)
    300 CRESCENT COURT, SUITE 1860

    (Street)
    DALLAS TX 75201

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    12/13/2024
    3. Issuer Name and Ticker or Trading Symbol
    AleAnna, Inc. [ ANNA ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit 24 - Power of Attorney
    No securities are beneficially owned.
    /s/ Tristan Yopp, attorney-in-fact 12/13/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $IVCP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IVCP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IVCP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Former CEO Bremner John

    4 - AleAnna, Inc. (0001845123) (Issuer)

    12/17/24 5:15:08 PM ET
    $IVCP
    Blank Checks
    Finance

    SEC Form 4 filed by Director Jones George L

    4 - AleAnna, Inc. (0001845123) (Issuer)

    12/17/24 5:15:06 PM ET
    $IVCP
    Blank Checks
    Finance

    Large owner Swiftmerge Holdings, Lp disposed of 2,706,012 shares (SEC Form 4)

    4 - AleAnna, Inc. (0001845123) (Issuer)

    12/17/24 5:15:05 PM ET
    $IVCP
    Blank Checks
    Finance

    $IVCP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AleAnna, Inc. Announces Completion of Business Combination between Swiftmerge Acquisition Corp. and AleAnna Energy, LLC

    Combination brings emerging leader in Italian natural gas and renewable natural gas to public marketsShares of AleAnna, Inc. to begin trading on Nasdaq on December 16 under the ticker symbol "ANNA"AleAnna stands on the cusp of a major milestone, with the first phase of natural gas production from the Longanesi Field projected to commence in Q1 2025 DALLAS and VANCOUVER, British Columbia and ROME, Dec. 13, 2024 (GLOBE NEWSWIRE) -- AleAnna, Inc. (together with its subsidiaries, "AleAnna" or the "Company"), an emerging leader in Italy's energy landscape, announced the completion of the previously announced business combination (the "Business Combination") between Swiftmerge Acquisition Corp.

    12/13/24 4:05:24 PM ET
    $IVCP
    Blank Checks
    Finance

    HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.

    $480 million Business Combination to Accelerate the Commercialization of an Innovative FDA-Approved Cardiovascular Disease Treatment HDL Therapeutics, Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia (HoFH), has signed a definitive merger agreement with Swiftmerge Acquisition Corp. (NASDAQ:IVCP) ("Swiftmerge"), a special purpose acquisition company with a disruptive consumer healthcare focused team. Under the terms of the merger agreement, a wholly-owned subsidiary of Swiftmerge will

    8/11/23 1:54:00 PM ET
    $IVCP
    Blank Checks
    Finance

    HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

    NASDAQ IVCP Swiftmerge Acquisition Corp ("Swiftmerge"), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a non-binding letter of intent ("LOI") for a business combination with HDL Therapeutics Inc. ("HDL Therapeutics"), a privately held commercial stage biotech company with an FDA-approved cardiovascular therapy for reducing coronary atheroma in homozygous familial hypercholesterolemia (HoFH) patients. HDL Therapeutics' platform, removes the highest risk plaques in coronary arteries that tend to rupture causing heart attacks and stroke. HDL expects this platform to have significant implications in the futur

    4/24/23 1:31:00 PM ET
    $IVCP
    Blank Checks
    Finance

    $IVCP
    SEC Filings

    View All

    SEC Form CERT filed by Swiftmerge Acquisition Corp.

    CERT - AleAnna, Inc. (0001845123) (Filer)

    12/13/24 5:25:53 PM ET
    $IVCP
    Blank Checks
    Finance

    SEC Form 15-12G filed by Swiftmerge Acquisition Corp.

    15-12G - AleAnna, Inc. (0001845123) (Filer)

    12/13/24 5:23:00 PM ET
    $IVCP
    Blank Checks
    Finance

    SEC Form 8-A12B filed by Swiftmerge Acquisition Corp.

    8-A12B - AleAnna, Inc. (0001845123) (Filer)

    12/13/24 4:45:49 PM ET
    $IVCP
    Blank Checks
    Finance

    $IVCP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Swiftmerge Acquisition Corp.

    SC 13G/A - Swiftmerge Acquisition Corp. (0001845123) (Subject)

    12/6/24 4:22:36 PM ET
    $IVCP
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Swiftmerge Acquisition Corp.

    SC 13G/A - Swiftmerge Acquisition Corp. (0001845123) (Subject)

    11/14/24 2:43:56 PM ET
    $IVCP
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by Swiftmerge Acquisition Corp.

    SC 13G/A - Swiftmerge Acquisition Corp. (0001845123) (Subject)

    11/14/24 1:56:08 PM ET
    $IVCP
    Blank Checks
    Finance